Filer Snapshot

Emerald Health Sciences Inc.

CIK 0001728413. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity Type

Company

Total Filings

29

Latest Filing

20 Mar 2023

Industry

n/a

Follow future filing-backed changes

Save this filer to return when a new filing changes the portfolio, large-stake, insider, or company context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Best next click

Start with the summary below, then verify the strongest source-backed page for this filer.

  • Open 13F if you want portfolio holdings.
  • Open 13D/G or insider pages only when this CIK has those rows.
Source: SEC Schedule 13D/G

SC 13D/A filed on 20 Mar 2023 for CIK 0001728413.

View Source Filing
Business address
Office 8262, The Landing, 200 375 Water St., Vancouver, British Columbia, Canada, V6B 0M9
Top holdings (ownership)
SKYE
State of incorporation
British Columbia, Canada
Fiscal year end
31 December

Filer intelligence

What SEC filings say about Emerald Health Sciences Inc.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for SKYE worth $3.17M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

SKYE

10 Nov 2022 ยท 10% owner

$3.17M

Latest update

What changed recently for Emerald Health Sciences Inc.

Ownership report updated

Latest ownership report period: 10 Nov 2022. Open the source-backed page to inspect the fresh filing or facts context.

Update date

17 Mar 2023

Page type

Ownership filings

Latest period

10 Nov 2022

Ownership context was refreshed from SEC Forms 3/4/5 filed on 17 Mar 2023.

Benchmark Context

Benchmark context for this company

Emerald Health Sciences Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest ownership report period: 10 Nov 2022. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Filer Overview

Emerald Health Sciences Inc. has filed 29 SEC EDGAR filings since 29 Jan 2018. Common forms include SC 13D/A, 4, D, 5 and more.

Latest Filings

Recent SEC filings for Emerald Health Sciences Inc. with direct links to document and filing folders.

SC 13D/A

SC 13D/A

Filing date
20 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4

Filing date
17 Mar 2023
Reporting date
10 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-457775

D filing

Filing date
01 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-457772

D filing

Filing date
01 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-457770

D filing

Filing date
01 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-457769

D filing

Filing date
01 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-457767

D filing

Filing date
01 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-457764

D filing

Filing date
01 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5 File 000-55136

FORM 5

Filing date
31 Jan 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
31 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
17 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A File 000-55136

FORM 4 A

Filing date
13 Aug 2020
Reporting date
07 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4

Filing date
11 Aug 2020
Reporting date
07 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
28 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4

Filing date
28 Jan 2020
Reporting date
20 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
01 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4

Filing date
01 Apr 2019
Reporting date
29 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90931

SC 13G

Filing date
19 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
04 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4 SUBMISSION

Filing date
01 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4 SUBMISSION

Filing date
28 Dec 2018
Reporting date
27 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
02 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4 SUBMISSION

Filing date
01 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4 SUBMISSION

Filing date
03 Apr 2018
Reporting date
29 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D AMENDMENT NO. 1

Filing date
05 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4 SUBMISSION

Filing date
02 Mar 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-55136

FORM 4 SUBMISSION

Filing date
21 Feb 2018
Reporting date
16 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D

SC 13D

Filing date
30 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 000-55136

FORM 3 SUBMISSION

Filing date
29 Jan 2018
Reporting date
18 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing

About this filer

Emerald Health Sciences Inc. files with the SEC under CIK 0001728413. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .